JP Morgan Chase’s Genelux GNLX Stock Holding History
Bought
Maintained
Sold
Other funds holding GNLX
WDC
BL
CM
FLPIM
GRP
JP Morgan Chase's GNLX Position: Q2 2026 in Review
JP Morgan Chase reduced its Genelux (GNLX) stake by 92% in Q2 2026, selling an estimated $897 and leaving 26 shares worth $75. The position accounts for ﹤0.01% of the portfolio, ranked #7557.
JP Morgan Chase first reported a position in GNLX in Q1 2023 and has held it in 14 quarters since. The position peaked at $308K in Q3 2023. 72 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.
- JP Morgan Chase held 26 shares of Genelux worth $75 as of Q2 2026.
- JP Morgan Chase sold 317 Genelux shares in Q2 2026, an estimated $897.
- Genelux made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7557 holding.
- JP Morgan Chase first reported a position in Genelux in Q1 2023 and has held it in 14 quarters since.
- JP Morgan Chase's Genelux position peaked at $308K in Q3 2023.
- 72 funds tracked by Wall St. Rank held Genelux as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.